Invesco Biotechnology & Genome ETF (PBE) Holdings List

$89.59 -0.35 (-0.39%)

As of 07/24/2026 04:10 PM Eastern

What stocks does PBE hold?

The Invesco Biotechnology & Genome ETF (PBE) top stock holdings include Vertex Pharmaceuticals, Amgen, and Royalty Pharma. The top 25 PBE holdings ordered by weight make up 89.05% of the total fund. PBE is an equity fund in the sector category that invests in publicly traded companies, focused on health care strategies within the North America region. This page includes a complete PBE stock holdings list ranked by weight, along with a full breakdown of sector, geographic, industry, and currency exposure.

Top 25 PBE Holdings

Rank	Company	Current Price	Weight	Shares Held
1	VRTX Vertex Pharmaceuticals	$477.36 +0.9%	4.98%	29,366
2	AMGN Amgen	$376.04 +1.2%	4.88%	38,102
3	RPRX Royalty Pharma	$58.83 -0.3%	4.83%	237,665
4	BIIB Biogen	$202.19 +0.8%	4.77%	66,296
5	REGN Regeneron Pharmaceuticals	$656.01 +0.6%	4.77%	20,169
6	CDNA CareDx	$37.14 -1.2%	4.50%	324,147
7	GILD Gilead Sciences	$129.31 -1.2%	4.49%	95,721
8	UTHR United Therapeutics	$528.47 -0.2%	4.14%	22,127
9	ALNY Alnylam Pharmaceuticals	$271.77 +1.1%	4.05%	43,319
10	TECH Bio-Techne	$71.60 -0.2%	3.67%	145,555
Get the Latest News and Ratings for PBE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Invesco Biotechnology & Genome ETF and its competitors with MarketBeat's FREE daily newsletter.
11	PTGX Protagonist Therapeutics	$136.11 +0.5%	3.44%	69,833
12	VCYT Veracyte	$56.61 -2.2%	3.26%	157,932
13	VCEL Vericel	$45.05 +0.0%	3.25%	199,662
14	ILMN Illumina	$194.09 -1.4%	3.14%	48,078
15	RGEN Repligen	$131.96 -4.1%	3.12%	60,614
16	INCY Incyte	$117.67 +0.8%	2.95%	71,907
17	ACAD ACADIA Pharmaceuticals	$24.84 +0.0%	2.94%	328,418
18	PTCT PTC Therapeutics	$76.82 -2.1%	2.83%	103,212
19	QGEN Qiagen	$41.38 -0.2%	2.83%	196,461
20	HALO Halozyme Therapeutics	$81.93 +1.3%	2.76%	101,605
21	BMRN BioMarin Pharmaceutical	$59.33 +0.8%	2.75%	132,040
22	EXEL Exelixis	$55.37 -0.5%	2.73%	139,699
23	NBIX Neurocrine Biosciences	$175.77 +0.9%	2.68%	44,836
24	BCRX BioCryst Pharmaceuticals	$9.34 -0.4%	2.68%	824,338
25	COLL Collegium Pharmaceutical	$35.20 -1.1%	2.61%	206,694

PBE Geographic Exposure

PBE's largest geographic exposure is United States at 97.2%, followed by Netherlands at 2.9%.

United States
97.2%
Netherlands
2.9%

PBE Currency Exposure

PBE is exclusively exposed to USD.

USD
95.2%

PBE Sector Exposure

PBE's largest sector exposure is Health Care at 97.2%.

Health Care
97.2%

PBE Industry Exposure

PBE's largest industry exposure is Biotechnology at 79.4%, followed by Health Care Equipment & Supplies at 17.8%.

Biotechnology
79.4%
Health Care Equipment & Supplies
17.8%

PBE Sub-Industry Exposure

PBE's largest sub-industry exposure is Biotechnology at 79.4%, followed by Life Sciences Tools & Services at 13.5%.

Biotechnology
79.4%
Life Sciences Tools & Services
13.5%
Health Care Equipment
4.3%

Related Companies and Tools

Related Companies

This page (NYSEARCA:PBE) was last updated on 7/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Invesco Biotechnology & Genome ETF (PBE) Holdings List